Core Viewpoint - Qinghai Spring is on the verge of delisting from the A-share market, transitioning from a peak as the "first stock of Cordyceps" to being labeled as *ST Spring, with significant concerns regarding its financial health and core business operations [1] Group 1: Financial Performance and Risks - For the first three quarters of 2025, Qinghai Spring reported a main business revenue of approximately 209 million yuan, with specific revenues from liquor at 87.68 million yuan, traditional Chinese medicine at 36.26 million yuan, and Cordyceps sales at 84.99 million yuan [2] - The company has adopted a credit sales strategy, leading to a significant accounts receivable of 67.89 million yuan for Cordyceps sales, raising concerns about the potential inability to recognize some sales revenue [2][4] - The company has not received terminal sales data from liquor distributors, which may affect revenue recognition, echoing previous concerns from the 2024 annual report regarding unrecognized revenue of 68.11 million yuan due to inventory and return risks [2] Group 2: Prepayment Issues - Qinghai Spring has over 100 million yuan in prepayments to Yibin Tinghua Wine Trading Co., with 140.18 million yuan outstanding as of September 30, 2025, raising regulatory concerns [3][4] - The company plans to reduce the prepayment balance to around 100 million yuan by the end of the year and align it with procurement scales by mid-2026 [4] - There is a risk of impairment for the prepayments due to potential delays in repayment from Yibin Tinghua, which could also impact the company's liquor sales business [4] Group 3: Delisting Risk - The company faces delisting risk as its audited profit totals for 2024 may fall below the thresholds set by the Shanghai Stock Exchange, with a warning that its stock could be suspended if financial metrics do not improve [5]

Core Viewpoint - *ST Chuntian received a warning letter from the Qinghai Securities Regulatory Bureau for failing to disclose its relationship with Yibin Tinghua and related transactions, violating information disclosure regulations [1][2]. Group 1: Regulatory Actions - The company was ordered to correct its actions due to non-disclosure of its relationship with Yibin Tinghua Wine Industry Development Co., Ltd. and related transactions [1][2]. - Four senior executives, including Chairman Zhang Xuefeng and actual controller Xiao Rong, received warning letters for their roles in the violations [1][2]. Group 2: Relationship with Yibin Tinghua - Yibin Tinghua is identified as a related entity to *ST Chuntian, as it is the producer of the company's alcoholic products, and the company has made advance payments to Yibin Tinghua for product procurement [2]. - The company failed to disclose the related party transactions and did not follow the necessary approval procedures, violating multiple provisions of the Information Disclosure Management Measures [2]. Group 3: Previous Concerns and Responses - There were previous concerns regarding potential benefit transfers to Yibin Tinghua, which the company denied in a response to the Shanghai Stock Exchange [4]. - The company stated that its collaboration with Yibin Tinghua was based on resource complementarity within the industry chain, and it emphasized that the advance payments were reasonable and related to its main business operations [5].